Sechenov School
Home › Pathophysiology › Principles of Liver Disease Treatment

Principles of Liver Disease Treatment

Curatio morborum hepatis

For medical students2 min readUpdated 2026-10-10

Therapy for hepatobiliary disorders relies on three fundamental pillars: etiotropic, pathogenetic, and symptomatic principles. The clinician's primary objective is not merely to alleviate disease manifestations, but to eliminate the underlying cause of cellular injury and disrupt the vicious cycles of pathological progression.

Main GoalElimination of etiological factors and disruption of pathogenetic links
HepatoprotectorsAct as critical membrane stabilizers for hepatocytes
Toxic Agents*Benzene*, *methanol*, and *carbon tetrachloride* are devastating to the organ
HomeostasisMandatory pharmacologic correction of acid-base balance and fluid-electrolyte status

Etiotropic Principle: Targeting the Root Cause

The fundamental foundation of successful treatment for any liver pathology is etiotropic therapy. Its primary goal is the complete elimination or significant reduction of the damaging effects exerted by various etiologic factors on hepatocytes. Without removing the cause, all other interventions remain merely temporary.

The main groups of damaging factors that require immediate removal include:

Pathogenetic Principle: Blocking Disease Mechanisms

Once the etiological factor has triggered a cascade of reactions, the pathogenetic principle comes to the forefront. Its key objective is to interrupt the links in the pathogenesis of liver diseases, pharmacologically blocking disease mechanisms to prevent further organ destruction.

To implement this principle in clinical practice, specific pharmacological classes are utilized:

  1. Anti-inflammatory agents — to suppress reactive and infectious inflammation within the organ tissue.
  2. Immunomodulators — to correct the immune response, which in liver diseases is often excessive or deficient.
  3. Antihypoxic agents (antihypoxants) — to protect hepatocytes under conditions of oxygen deprivation.
  4. Membrane stabilizers — specific agents widely known as hepatoprotectors, designed to reinforce the phospholipid bilayer of hepatocyte cell walls and prevent lysis.

Correction of Homeostasis as Part of Pathogenetic Therapy

Liver pathology inevitably leads to severe systemic shifts in the body. Therefore, a vital component of pathogenetic treatment is the strict correction of homeostasis, requiring close monitoring of the patient's internal environment.

Key directions of correction include:

Thus, the overall strategy for managing patients with various forms of liver pathology is always based on the strict integration of etiopathogenetic and symptomatic approaches.

Mnemonic

To remember the three pillars of treatment, recall the EPS acronym: E — Etiotropic (eliminating toxins and viruses), P — Pathogenetic (protecting membranes, administering antihypoxants), S — Symptomatic.

Frequently asked questions

What specific symptoms and syndromes are targeted in symptomatic therapy for liver diseases?

Based on clinical sources regarding liver pathology management:

  • In NAFLD: alleviation of hepatogenic fatigue and asthenia;
  • In cholestatic forms of acute viral hepatitis: resolution of cholestatic syndrome and relief of pruritus;
  • In pediatric cirrhosis: syndromic management of ascites;
  • In severe forms of hepatitis: management of cerebral edema and brain swelling.

Additionally, during the convalescence period of acute hepatitis B, dyspepsia management is indicated.

What specific drugs or active substances belong to membrane stabilizers (hepatoprotectors)?

According to the sources, specific agents classed as hepatoprotectors or membrane-stabilizing/hepatoprotective therapy include:

  • Ademetionine — listed among hepatoprotectors;
  • Ursodeoxycholic acid (UDCA) — indicated as a drug of choice among hepatoprotectors and choleretics, and classified under bile acids;
  • Essential phospholipids (EPLs) — considered for adjunctive use in complex NAFLD therapy.

For acute hepatitis C, sources mention the group of "amino acids, their derivatives, and other drugs for liver disease" aimed at improving tissue metabolism and stabilizing cell membranes, though without naming a specific active substance.

What is the primary goal of the etiopathogenetic principle in liver disease?

Its goal is the complete elimination or maximal reduction of the damaging impact of etiologic factors (toxins, drugs, viruses, ischemia) on the liver.

Which drug classes are used in pathogenetic therapy for liver pathologies?

Anti-inflammatory agents, immunomodulators, antihypoxants, and membrane stabilizers (hepatoprotectors) are used to interrupt pathogenetic mechanisms.

Which homeostasis parameters require mandatory correction?

It is essential to normalize acid-base status parameters as well as correct the patient's fluid and electrolyte balance.

Go deeper

More topics in Pathophysiology

Tumor Invasive GrowthEarly Stage of Substance AddictionTraumatic and Burn ShockLeukopenia: Pathophysiology, Causes, and MechanismsMyocardial InjuryGastric Achylia and Secretory DisordersCushing SyndromePathophysiology of PainAlterations of ConsciousnessEtiology and PathogenesisCongenital MalformationsApoptosis: Mechanism, Stages, and Differences from NecrosisPathophysiology →